Latest studies showed that bacteria-infecting viruses called bacteriophages, or simply phages, could kill different strains of the bacterium E. coli by making mutations in a viral protein that bound to host cells.
A drug known as colistin is still being used as a growth promoter in animals. Colistin is classified by the World Health Organization as antibiotic that should only be used to treat infections when everything else has failed.
Each year, farmers in the U.S. purchase tens of millions of pounds of antibiotics that are approved for use in cows, pigs, fowl and other livestock.
The research led to the identification of two synthetic retinoids, both of which demonstrated the ability to kill MRSA (methicillin-resistant Staphylococcus aureus), a type of staph bacteria that is resistant to several antibiotics.
A report led by the Bureau of Investigative Journalism reveals that thousands of tonnes of colistin – what medics refer to as the “last hope antibiotic” – is being shipped to countries like India for use in livestock farming.
Antibiotics could become nearly useless by mid-century against intense infections due to bacteria evolving antibiotic resistance. It's time to develop alternatives to antibiotics for small infections.
Human travel and shipping is transporting trillions of bacteria around the globe with unexpected effects.
The new discovery shows promise in helping to treat the millions infected each year with antibiotic-resistant superbugs.
Teams of scientists are now working on a truly creative strategy: a pill carrying the genome-editing power tool CRISPR that instructs harmful bacteria to shred their own genes to bits.
Now, researchers in Cleveland, Ohio have taken a significant step toward defeating antibiotic-resistant infections by combining two different antibiotics that each block a different kind of drug-destroying enzyme secreted by bacteria.
The World Health Organization has issued a list of the top dozen bacteria most dangerous to humans, warning that doctors are fast running out of treatment options.
Sending an antibiotic-resistant superbug to a zero-gravity environment like the International Space Station will help NASA better understand how superbugs mutate to become resistant to available antibiotics.
Finnish researchers confirmed that those traveling to exotic locations often bring home drug-resistant bacteria in their intestines. But the people who took antibiotics while exploring those locales came back with the most extensively drug-resistant cargo.